Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients

MLA

Kun Zhu, et al. “Cyclophosphamide, Epirubicin and Fluorouracil Chemotherapy-Induced Alteration of Haemostasis Markers in Breast Cancer Patients.” Molecular and Clinical Oncology, vol. 3, June 2015, pp. 1088–92. EBSCOhost, https://doi.org/10.3892/mco.2015.584.

APA

Kun Zhu, Peng Xia, Zhi Wang, Kang Li, Yongchun Song, Dongmin Chang, Yong Zhang, & Chengxue Dang. (2015). Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients. Molecular and Clinical Oncology, 3, 1088–1092. https://doi.org/10.3892/mco.2015.584

Chicago

Kun Zhu, Peng Xia, Zhi Wang, Kang Li, Yongchun Song, Dongmin Chang, Yong Zhang, and Chengxue Dang. 2015. “Cyclophosphamide, Epirubicin and Fluorouracil Chemotherapy-Induced Alteration of Haemostasis Markers in Breast Cancer Patients.” Molecular and Clinical Oncology 3 (June): 1088–92. doi:10.3892/mco.2015.584.